Share on facebook
Share on twitter
Share on linkedin
Share on telegram
Share on whatsapp

The directors of AstraZeneca are members of the Graphene Flagship project

Share on facebook
Share on twitter
Share on telegram
Share on email
Share on print

The Graphene Flagship values ethics in all aspects of the project, from research topics to to societal implications.

The following three areas are of particular interest, but may change as the Flagship progresses towards higher technology readiness level (TRL):

  • Ethics of biological, health and environmental effects of graphene, and on biomedical and related applications. Any of these might involve in vitro research, small or large animal models, and eventually human interventions.
  • Dual use. While all the research has an exclusively civilian focus, some of the technologies developed might find broader uses. This issue is becoming more important as the Flagship moves to higher TRLs.
  • Responsible research and innovation. Since the Flagship covers a very broad range of topics, it has a wide variety of societal connections.

The EAB’s role is to advise on:

  • Flagship activities to ensure ethical use of materials and animals.
  • The possible environmental and ethical implications from technologies developed by the Graphene Flagship.
  • How regulations proposed by environmental protection agencies or consumer groups may affect the progress and development of graphene objectives or any of its S&T products.
  • The use of reflection tools and practices for identifying and addressing ethical issues.
Notify of
Inline Feedbacks
View all comments
Would love your thoughts, please comment.x

Get in Touch!

Purpose of your Contact
Where can i reach you?
What would you like to discuss?

Are you intending to visit the Lorphic marketing agency?